SMAD3 and renal cell carcinoma: To end this, we used TGF‐β1 inhibitor, which was confirmed in Figure 5D by examination of TGF‐β1 and p‐Smad3, to test whether it could attenuate MUC12 mediated cell growth and cell invasion in RCC cells.